
AbstractWe report two patients with PMM2‐CDG who developed end stage renal disease (ESRD). Renal abnormalities of clinical significance have only been reported in about 6% of patients with PMM2‐CDG and have rarely been reported as the cause of death. Given the recurrent episodes of acute kidney injury associated with hospital admissions and the accelerated development of ESRD thereafter in our two patients, we recommend proactively involving Nephrology early in the care of these patients.
UPC—urine protein‐to‐creatinine ratio, ESRD—toll‐like receptor, PMM2—end stage renal disease, Case Reports, QH426-470, RC648-665, Diseases of the endocrine glands. Clinical endocrinology, CDG—chronic kidney disease, Genetics, CKD—phosphomannosemutase‐2, TLR—congenital disorder of glycosylation
UPC—urine protein‐to‐creatinine ratio, ESRD—toll‐like receptor, PMM2—end stage renal disease, Case Reports, QH426-470, RC648-665, Diseases of the endocrine glands. Clinical endocrinology, CDG—chronic kidney disease, Genetics, CKD—phosphomannosemutase‐2, TLR—congenital disorder of glycosylation
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 4 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
